Biocon Ltd

Biocon Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Biocon Ltd

₹ 322 0.93%
30 Apr - close price
biocon.com BSE: 532523 NSE: BIOCON
About

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

Key Points

Business Segments
1.Biosimilars (~60% in FY24 vs ~50% in FY23):[1] Managed by Biocon Biologics, this segment has a portfolio of 20 biosimilars spanning across oncology, immunology, diabetes and other therapeutic areas. [2] It has gained market share in its key products, including bTrastuzumab, bPegfilgrastim, bGlargine, and bBevacizumab in the advanced markets. [3][4] It has a pipeline of 20+ molecules to be launched by 2030. [5]

Website BSE NSE
  • Market Cap ₹ 38,635 Cr.
  • Current Price ₹ 322
  • High / Low ₹ 405 / 270
  • Stock P/E 46.9
  • Book Value ₹ 175
  • Dividend Yield 0.16 %
  • ROCE 5.96 %
  • ROE 5.25 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 18.0%

Cons

  • Company has a low return on equity of 5.87% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.1,318 Cr.
  • Company has high debtors of 154 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE Allcap BSE Dollex 200 Nifty 500 BSE 250 LargeMidCap Index BSE 400 MidSmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
2,174 2,409 2,140 2,320 2,941 3,774 3,423 3,462 3,954 3,917 3,433 3,590 3,821
1,733 1,870 1,783 1,877 2,352 2,817 2,741 2,745 3,051 3,004 2,812 2,905 3,070
Operating Profit 441 539 356 442 589 957 681 717 903 913 620 685 752
OPM % 20% 22% 17% 19% 20% 25% 20% 21% 23% 23% 18% 19% 20%
48 26 78 48 -193 152 94 134 587 40 1,166 58 53
Interest 15 10 20 30 120 249 233 248 267 227 236 226 223
Depreciation 206 212 218 231 301 364 358 389 414 407 405 420 425
Profit before tax 269 342 197 229 -26 497 184 214 808 319 1,146 98 156
Tax % 18% 17% 15% 64% -19% 17% 19% 19% 7% 30% 25% 72% 48%
220 284 167 82 -21 414 149 173 753 223 862 27 81
EPS in Rs 1.56 1.99 1.20 0.39 -0.35 2.61 0.84 1.05 5.50 1.13 5.49 -0.13 0.21
Raw PDF
Upcoming result date: 8 May 2025

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
2,485 2,877 3,090 3,347 3,891 4,123 5,514 6,300 7,143 8,184 11,174 14,756 14,762
1,942 2,190 2,394 2,957 2,912 3,294 4,121 4,725 5,562 6,391 8,762 11,540 11,791
Operating Profit 543 687 696 390 980 829 1,394 1,575 1,581 1,793 2,412 3,216 2,971
OPM % 22% 24% 23% 12% 25% 20% 25% 25% 22% 22% 22% 22% 20%
255 56 158 639 173 228 340 228 260 72 18 853 1,318
Interest 8 2 9 29 26 62 71 65 58 68 419 974 912
Depreciation 179 204 221 249 277 385 448 552 715 814 1,113 1,569 1,658
Profit before tax 610 538 624 751 850 610 1,215 1,186 1,068 983 897 1,525 1,719
Tax % 16% 20% 15% 19% 19% 26% 17% 27% 21% 22% 28% 15%
513 431 528 609 688 453 1,003 871 846 772 643 1,298 1,193
EPS in Rs 4.24 3.45 4.14 4.59 5.10 3.10 7.54 6.24 6.17 5.40 3.85 8.52 6.70
Dividend Payout % 29% 24% 20% 18% 10% 16% 7% 0% 0% 9% 39% 6%
Compounded Sales Growth
10 Years: 18%
5 Years: 22%
3 Years: 27%
TTM: 1%
Compounded Profit Growth
10 Years: 9%
5 Years: 6%
3 Years: 11%
TTM: -31%
Stock Price CAGR
10 Years: 16%
5 Years: -2%
3 Years: -5%
1 Year: 8%
Return on Equity
10 Years: 8%
5 Years: 7%
3 Years: 6%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 100 100 100 100 100 300 300 600 600 600 600 600 600
Reserves 2,595 2,927 3,171 3,934 4,738 4,881 5,798 6,106 7,027 7,832 17,267 19,183 20,393
267 864 1,117 2,478 2,302 2,264 2,422 2,715 4,481 5,147 18,019 16,277 16,771
1,454 1,860 1,988 1,947 2,254 2,545 3,672 4,993 6,382 6,763 15,856 19,693 19,364
Total Liabilities 4,416 5,751 6,375 8,458 9,394 9,990 12,192 14,414 18,490 20,342 51,742 55,753 57,128
1,510 1,525 1,630 1,748 3,626 3,700 4,471 5,971 6,364 6,569 29,468 30,644 34,792
CWIP 312 1,206 1,677 2,240 839 1,303 1,899 2,196 2,800 4,110 7,317 7,993 4,354
Investments 587 765 230 902 1,253 675 1,012 966 1,952 1,588 2,069 1,000 1,809
2,007 2,255 2,839 3,569 3,676 4,312 4,811 5,281 7,374 8,074 12,888 16,117 16,174
Total Assets 4,416 5,751 6,375 8,458 9,394 9,990 12,192 14,414 18,490 20,342 51,742 55,753 57,128

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
471 561 211 371 640 662 1,155 1,283 1,160 1,177 1,852 2,954
-358 -904 -491 -1,138 -510 -684 -703 -1,505 -3,651 -1,662 -14,260 -1,002
-9 426 186 1,068 -178 -240 -242 388 2,564 242 13,049 -2,333
Net Cash Flow 105 83 -94 300 -47 -261 210 165 72 -243 641 -380

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 75 76 91 78 83 94 86 71 77 92 117 154
Inventory Days 139 116 132 153 160 161 199 263 304 309 423 368
Days Payable 121 107 125 172 187 224 231 243 246 216 383 467
Cash Conversion Cycle 93 85 98 59 57 31 53 91 134 184 157 55
Working Capital Days 21 -0 12 31 34 18 15 8 80 112 85 2
ROCE % 15% 15% 12% 9% 12% 8% 13% 12% 10% 9% 6% 6%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
60.64% 60.64% 60.64% 60.64% 60.64% 60.64% 60.64% 60.64% 60.64% 60.64% 60.64% 60.64%
16.31% 15.79% 14.42% 10.20% 9.52% 7.97% 6.55% 5.63% 5.90% 5.93% 5.66% 5.67%
7.72% 7.76% 8.63% 11.89% 12.59% 14.08% 14.51% 13.69% 14.29% 14.44% 15.36% 15.73%
14.60% 15.17% 15.74% 16.70% 16.77% 16.92% 17.96% 19.74% 18.90% 18.74% 18.11% 17.77%
0.73% 0.63% 0.58% 0.55% 0.49% 0.39% 0.33% 0.32% 0.28% 0.25% 0.22% 0.21%
No. of Shareholders 3,41,0163,69,8163,91,3824,11,0864,12,4414,15,0464,34,3394,70,2614,43,5134,39,5034,27,7054,24,297

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls